A detailed history of Mitsubishi Ufj Kokusai Asset Management Co., Ltd. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Mitsubishi Ufj Kokusai Asset Management Co., Ltd. holds 1,758,645 shares of GILD stock, worth $155 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares
1,758,645
Previous 1,571,510 11.91%
Holding current value
$155 Million
Previous $115 Million 4.82%
% of portfolio
0.15%
Previous 0.16%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$63.15 - $72.88 $11.8 Million - $13.6 Million
187,135 Added 11.91%
1,758,645 $121 Million
Q1 2024

May 09, 2024

BUY
$71.58 - $87.29 $18.3 Million - $22.3 Million
255,382 Added 19.4%
1,571,510 $115 Million
Q4 2023

Feb 08, 2024

BUY
$73.27 - $83.09 $5.93 Million - $6.72 Million
80,872 Added 6.55%
1,316,128 $107 Million
Q3 2023

Nov 07, 2023

BUY
$73.94 - $80.67 $7.61 Million - $8.3 Million
102,885 Added 9.09%
1,235,256 $92.6 Million
Q2 2023

Aug 09, 2023

BUY
$76.01 - $86.7 $5.03 Million - $5.74 Million
66,182 Added 6.21%
1,132,371 $87.3 Million
Q1 2023

May 08, 2023

BUY
$77.31 - $88.08 $7.82 Million - $8.9 Million
101,100 Added 10.48%
1,066,189 $88.5 Million
Q4 2022

Feb 07, 2023

BUY
$62.32 - $89.47 $6.39 Million - $9.18 Million
102,576 Added 11.89%
965,089 $82.9 Million
Q3 2022

Nov 01, 2022

BUY
$59.54 - $68.01 $4.65 Million - $5.31 Million
78,037 Added 9.95%
862,513 $53.2 Million
Q2 2022

Aug 04, 2022

BUY
$57.72 - $65.01 $3.88 Million - $4.37 Million
67,266 Added 9.38%
784,476 $48.5 Million
Q1 2022

May 09, 2022

BUY
$57.92 - $72.58 $3.5 Million - $4.39 Million
60,491 Added 9.21%
717,210 $42.6 Million
Q4 2021

Feb 07, 2022

BUY
$64.88 - $73.64 $6.53 Million - $7.41 Million
100,587 Added 18.09%
656,719 $47.7 Million
Q3 2021

Nov 04, 2021

BUY
$67.69 - $73.03 $4.01 Million - $4.33 Million
59,229 Added 11.92%
556,132 $38.8 Million
Q2 2021

Aug 06, 2021

BUY
$63.47 - $69.35 $4.11 Million - $4.49 Million
64,690 Added 14.97%
496,903 $34.2 Million
Q1 2021

May 06, 2021

BUY
$60.0 - $68.46 $3.38 Million - $3.86 Million
56,331 Added 14.99%
432,213 $27.9 Million
Q4 2020

Feb 09, 2021

BUY
$56.65 - $64.55 $1.07 Million - $1.22 Million
18,906 Added 5.3%
375,882 $21.9 Million
Q3 2020

Nov 10, 2020

BUY
$62.1 - $78.08 $3.17 Million - $3.98 Million
51,019 Added 16.68%
356,976 $22.6 Million
Q2 2020

Aug 06, 2020

BUY
$72.34 - $84.0 $3.46 Million - $4.02 Million
47,887 Added 18.56%
305,957 $23.5 Million
Q1 2020

May 11, 2020

BUY
$62.63 - $80.22 $310,081 - $397,169
4,951 Added 1.96%
258,070 $19.3 Million
Q4 2019

Feb 05, 2020

BUY
$61.62 - $67.78 $444,649 - $489,100
7,216 Added 2.93%
253,119 $16.5 Million
Q3 2019

Nov 12, 2019

SELL
$62.51 - $69.0 $2.55 Million - $2.82 Million
-40,851 Reduced 14.25%
245,903 $15.6 Million
Q2 2019

Aug 08, 2019

SELL
$61.87 - $69.38 $3.78 Million - $4.24 Million
-61,129 Reduced 17.57%
286,754 $19.4 Million
Q1 2019

Apr 26, 2019

BUY
$62.53 - $70.05 $4.91 Million - $5.5 Million
78,506 Added 29.14%
347,883 $22.6 Million
Q4 2018

Feb 08, 2019

SELL
$60.54 - $79.0 $4.33 Million - $5.65 Million
-71,468 Reduced 20.97%
269,377 $17.6 Million
Q3 2018

Nov 13, 2018

SELL
$71.28 - $78.92 $850,512 - $941,673
-11,932 Reduced 3.38%
340,845 $26.3 Million
Q2 2018

Aug 09, 2018

BUY
$64.88 - $75.68 $4.88 Million - $5.69 Million
75,199 Added 27.09%
352,777 $25 Million
Q1 2018

May 02, 2018

SELL
$72.84 - $88.8 $2.17 Million - $2.64 Million
-29,740 Reduced 9.68%
277,578 $20.9 Million
Q4 2017

Feb 06, 2018

SELL
$71.15 - $83.52 $4.47 Million - $5.24 Million
-62,784 Reduced 16.96%
307,318 $22.9 Million
Q3 2017

Nov 01, 2017

BUY
$72.11 - $85.47 $26.7 Million - $31.6 Million
370,102
370,102 $30 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.